July 16 Financial Quick Takes: J&J growth drivers beat consensus; plus Notable and Cradle raise funds

By Paul Bonanos, Associate Editor | Jul 16, 2019 | 8:29 PM GMT

Imbruvica, Darzalex sales top analysts' consensus
In its 2Q19 earnings report, Johnson & Johnson (NYSE:JNJ) said revenue from its pharmaceutical